Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
NVNO | US
0.03
0.94%
Healthcare
Medical Devices
30/06/2024
04/10/2024
3.23
3.21
3.31
3.19
enVVeno Medical Corporation a clinical med-tech company focuses on the development of various bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous diseases. The company's lead product is the VenoValve a surgical implant being developed for the treatment of chronic venous disease. Its VenoValve is implanted in the femoral vein and acts as a one-way valve to help restore proper blood flow in the leg. The company was formerly known as Hancock Jaffe Laboratories Inc. and changed its name to enVVeno Medical Corporation in October 2021. enVVeno Medical Corporation was incorporated in 1999 and is based in Irvine California.
View LessLow Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Value Stock (Price to Book < 3)
Price Below SMA10D
High Short-term Volatility
Microcap (<300M USD)
High Market Beta (> 0.8)
Weak Sharpe Ratio (< 0.3)
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
10 days
143.4%1 month
102.8%3 months
74.9%6 months
61.5%-
-
1.12
0.03
0.03
-0.87
-
-
-22.37M
43.06M
43.06M
-
-
-
-
-61.28
16.77
5.99
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
2.06
Range1M
2.64
Range3M
3.42
Rel. volume
0.37
Price X volume
246.08K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Apyx Medical Corporation | APYX | Medical Instruments & Supplies | 1.275 | 44.17M | 6.83% | n/a | 262.43% |
Lucid Diagnostics Inc. Common Stock | LUCD | Medical Devices | 0.8101 | 39.97M | -4.12% | n/a | 89.10% |
RAPID MICRO BIOSYSTEMS INC. | RPID | Medical Devices | 0.9 | 38.62M | 2.39% | n/a | 7.18% |
Move Inc | MOVE | Medical Devices | 0.361 | 35.72M | 2.21% | n/a | 0.85% |
Vicarious Surgical Inc. | RBOT | Medical Devices | 5.71 | 33.67M | 1.42% | n/a | 19.94% |
Singular Genomics Systems Inc. Common Stock | OMIC | Medical Instruments & Supplies | 13.48 | 33.64M | -12.35% | n/a | 54.99% |
Outset Medical Inc | OM | Medical Devices | 0.621 | 32.35M | 0.58% | n/a | 294.91% |
Vaso Corporation | VASO | Medical Devices | 0.185 | 32.00M | -2.48% | 9.00 | 0.00% |
Precision Optics Corporation Inc. Common stock | POCI | Medical Instruments & Supplies | 4.775 | 30.32M | -4.50% | n/a | 26.79% |
IceCure Medical Ltd. Ordinary Shares | ICCM | Medical Devices | 0.6071 | 30.06M | 1.18% | n/a | 4.90% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
The InterGroup Corporation | INTG | Real Estate Services | 16.4 | 35.87M | 7.75% | n/a | -257.98% |
Beasley Broadcast Group Inc | BBGI | Broadcasting - Radio | 12.89 | 19.79M | -2.50% | n/a | 204.46% |
ILAG | ILAG | Building Products & Equipment | 1.0599 | 19.14M | -0.93% | n/a | 5.48% |
FANGDD NETWORK GROUP LTD. | DUO | Real Estate Services | 2.53 | 16.35M | -42.24% | n/a | 0.07% |
Ohmyhome Limited Ordinary Shares | OMH | Real Estate Services | 0.4699 | 10.71M | 3.94% | n/a | 22.77% |
MDJM Ltd | MDJH | Real Estate Services | 0.657 | 10.51M | 1.56% | n/a | 0.00% |
LuxUrban Hotels Inc. | LUXH | Real Estate Services | 0.0767 | 10.50M | 3.09% | n/a | -387.21% |
La Rosa Holdings Corp. Common Stock | LRHC | Real Estate Services | 0.606 | 10.40M | -3.81% | n/a | 76.18% |
Antelope Enterprise Holdings Limited | AEHL | Building Products & Equipment | 0.695 | 8.47M | -4.15% | n/a | 16.03% |
ALBT | ALBT | Real Estate Services | 0.2137 | 3.42M | 6.85% | n/a | 187.39% |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | -0.87 | 45.99 | Cheaper |
Ent. to Revenue | - | 13.20 | - |
PE Ratio | - | 29.98 | - |
Price to Book | 1.12 | 6.06 | Cheaper |
Dividend Yield | - | 1.65 | - |
Std. Deviation (3M) | 74.94 | 66.08 | Par |
Debt to Equity | 0.03 | 0.83 | Cheaper |
Debt to Assets | 0.03 | 0.28 | Cheaper |
Market Cap | 43.06M | 9.42B | Emerging |